AI Article Synopsis
- VCAM-1 is linked to inflammatory diseases, but its specific role in diabetic retinopathy (DR) is not well understood and is under-researched.
- A study analyzed 20 articles and found that VCAM-1 levels were significantly higher in patients with DR compared to controls, indicating a strong connection to the condition's severity.
- The findings suggest that VCAM-1 could serve as a valuable biomarker for detecting and assessing the severity of diabetic retinopathy.
Article Abstract
Objective: Vascular cell adhesion molecule-1 (VCAM-1) plays a regulatory role in inflammatory diseases. However, the exact role of VCAM-1 in diabetic retinopathy (DR) remains unclear, and there is a lack of meta-analyses.
Methods: The role of VCAM-1 in DR was screened by database searching. A random effects model was used, and the estimated mean difference was evaluated.
Results: Twenty articles were included. The level of VCAM-1 increased significantly in the DR group compared with the control group (SMD: 0.67, 95 % CI: 0.34-1.01, P < 0.0001). VCAM-1 levels correlated with sample size and DR type, method and severity based on subgroup analysis.
Conclusion: A high level of VCAM-1 is present in DR patients and is related to the severity of DR. Therefore, VCAM-1 is a potential detection biomarker for DR.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jdiacomp.2022.108380 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!